In the derivation study that led to the drafting of the 2010 ACR/EULAR classification criteria for RA, moderate or high ACPA titer was the main predictive factor for the initiation of a cs-DMARD [12]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.